Leukemia Clinical Trials

Showing 3601-3620 of 10,987 trials

Safety and Efficacy of CAR T Cell Therapy in Patients with R/r B-ALL

NCT06635330

The goal of this clinical trial is to evaluate the safety and efficacy of CD19 CAR-T cells in pediatric patients of all genders, aged 2 to 18 years, with relapsing or refractory B cell acute lymphoblastic leukemia (r/r B-ALL). The main questions it aims to answer are as following: 1. What is the percentage of patients with overall remission rate (ORR) of complete response (CR) or complete remission with incomplete blood count recovery (CRi)? 2. What is the rate of Event-free survival at first month and 2-3 months after intervention? 3. What is the rate of Overall survival at first month and at 3 months after the intervention?

Relapse/Refractory B-cell Acute Lymphoblastic Leukemia

Kara Yakhteh Tajhiz Azma Company5 participantsStarted May 2024

Tehran, Tehran Province, Iran

RECRUITING

The Pediatric Spine Foundation

NCT02540915

The Pediatric Spine Foundation is a registry designed to assist spine surgeons to efficiently identify and track patients with chest wall and spinal disorders.

Chest Wall and Spinal Disorders

University of Colorado, Denver5,000 participantsStarted Nov 2013

Aurora, Colorado, United States

TERMINATEDPhase 1/2

DS-3201b and Irinotecan for Patients With Recurrent Small Cell Lung Cancer

NCT03879798

This study will test the safety of the study drug, DS-3201b, given in combination with irinotecan to people who have recurrent small cell lung cancer (SCLC).

Small Cell Lung Cancer

Memorial Sloan Kettering Cancer Center22 participantsStarted Mar 2019

Basking Ridge, New Jersey, United States • Middletown, New Jersey, United States • Montvale, New Jersey, United States +4 more locations

Safety and Efficacy of CAR T Cell Therapy in Patients with R/r B-ALL

The Pediatric Spine Foundation

DS-3201b and Irinotecan for Patients With Recurrent Small Cell Lung Cancer

Related Searches

Third-generation EGFR-TKI Plus Anlotinib as Maintenance for NSCLC With Small Cell Transformation After EGFR-TKI Resistance

An Investigator-Initiated, Phase II, Multicenter, Open-Label, Single-Arm, Prospective Clinical Trial to Evaluate the Efficacy and Safety of Alternating Bortezomib-Based Regimens in Combination With DaratUMumab Followed by Maintenance With Daratumumab in the Frontline Setting of Primary Plasma CEll L

Efficacy of Venetoclax Combined with Intensive Chemotherapy in Different Subgroups of AML

Itacitinib and Alemtuzumab in Treating Patients With T-Cell Prolymphocytic Leukemia

Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors

Effects of Oral Aloe Vera Juice on Chemotherapy and Radiation-induced Oral Mucositis and Esophagitis

Pembrolizumab in Patients With Metastatic Non-squamous Non-small Cell Lung Cancer

Secondary Sclerosis Cholangitis Prospective

Brief Title: Study of Efficacy and Safety of Canakinumab as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II-IIIA and IIIB (T>5cm N2) Completely Resected Non-small Cell Lung Cancer Acronym: CANOPY-A

Lintuzumab-Ac225 in Combination with Cladribine + Cytarabine + Filgastrim + Mitoxantrone (CLAG-M) for Relapsed/Refractory Acute Myeloid Leukemia

A Study of Carboplatin-Paclitaxel/Nab-Paclitaxel Chemotherapy With or Without Pembrolizumab (MK-3475) in Adults With First Line Metastatic Squamous Non-small Cell Lung Cancer (MK-3475-407/KEYNOTE-407)

Assess the Performance of Metagenomic Sequencing in the Diagnosis of STI (NGS-IST)

Phase I/II Eval Safety & Prelim Activity Nivolumab Comb W/Vorolanib Pts W/Refractory Thoracic Tumors

Association of Urinary Incontinence With Depression, Insomnia, Frailty and Falls in Older Adults

Integrative "Omics" Approaches for Leukemia Target Identification and Matched Therapeutic Intervention

Venetoclax + Decitabine vs. "7+3" Induction Chemotherapy in Young AML

Safety and Anti-Tumor Activity of TYRA-200 in Advanced Cholangiocarcinoma With Activating FGFR2 Gene Alterations